US drug policy has become increasingly privatised in recent years as the US government contracts private military and security companies (PMSCs) to provide intelligence, logistical support and training to state security forces in drug-producing and –transit states. As the cases of Colombia and Mexico illustrate, this privatisation strategy is having a damaging impact on these already fragile environments.